Design Therapeutics (DSGN) Interest & Investment Income (2021 - 2026)

Design Therapeutics has reported Interest & Investment Income for 6 years, with the latest figure at $2.0 million in Q2 2026.

• Interest & Investment Income for Q2 2026 came in at $2.0 million, down 19.07% year-over-year; the trailing twelve-month figure through Jun 2026 was $8.6 million (down 25.1% YoY), and the FY2025 annual result was $9.7 million, down 24.38% from the prior year.
• Interest & Investment Income declined to $2.0 million in Q2 2026, from $2.1 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $9.3 million in Q4 2023 and troughed at -$1.5 million in Q3 2022.
• A 5-year average of $1.9 million and a median of $2.1 million in 2025 frame the typical range for Interest & Investment Income.
• The widest annual swing landed in 2022, when Interest & Investment Income plunged 19425.0%; it then surged 18155.56% in 2024.
• A 5-year view of Interest & Investment Income shows it stood at $505000.0 in 2022, then soared by 1732.67% to $9.3 million in 2023, then slumped by 67.12% to $3.0 million in 2024, then decreased by 28.62% to $2.2 million in 2025, then decreased by 7.37% to $2.0 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $2.0 million in Q2 2026, $2.1 million in Q1 2026, and $2.2 million in Q4 2025.